EUDA Health (NASDAQ:EUDA) Announces Quarterly Earnings Results

EUDA Health (NASDAQ:EUDA) issued its earnings results on Tuesday. The company reported ($0.17) EPS for the quarter, reports. The firm had revenue of $1.73 million for the quarter.

EUDA Health Trading Down 1.9%

EUDA stock traded down $0.30 during midday trading on Tuesday, reaching $15.90. 5,437 shares of the stock were exchanged, compared to its average volume of 51,524. EUDA Health has a 52 week low of $5.26 and a 52 week high of $86.00. The company has a fifty day moving average price of $15.53 and a 200 day moving average price of $13.62.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of EUDA Health in a report on Wednesday, August 5th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $55.00.

EUDA Health Company Profile

EUDA Health Holdings Limited is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services.

Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions.

The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market.